Month: May 2025

New trial for gene therapy for frontotemporal dementia

The ASPIRE-FTD clinical trial will investigate the use of a gene therapy in people with frontotemporal dementia. A new clinical trial, delivered in Cardiff, will investigate the use of a one-time gene therapy to stop the disease progression in patients with frontotemporal dementia. The ASPIRE-FTD…

SEE MORE